PREFER webinar on designing and applying results from patient preference studies

Описание: This is a recorded webinar that introduces the PREFER framework for patient preference studies, with a particular focus on points to consider for method selection and the application of preference study results to inform regulatory and HTA decision-making. The webinar (Designing and applying results from patient preference studies: the PREFER framework) was held on August 31, 2021.

Introduction to the PREFER framework & what we’d like this to achieve - Conny Berlin, IMI PREFER Project Leader & Global Head, Quantitative Safety and Epidemiology Novartis Pharma AG, Switzerland
How the PREFER framework addresses the study purpose; study organization, design & conduct - Kristin Bullok, Benefit-Risk Management Scientist, Global Patient Safety; Eli Lilly and Company, United States
Points to consider for method selection - Brett Hauber, Senior Director, Patient Preference Elicitation Pfizer, United States
PREFER framework continued: application of preference data to inform regulatory decision-making - Bennett Levitan, Senior Director, Benefit-Risk Assessment, Global R&D Epidemiology; Janssen Research & Development, United States
PREFER framework continued further: application of preference data to inform HTA decision-making - Irina Cleemput, Scientific Programme Director Belgian Health Care Knowledge Centre (KCE), Belgium

For more information about the project visit https://www.imi-prefer.eu/